Fate Therapeutics (FATE) P/FCF US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| P/FCF | -26.0 | -3.44 | -2.66 | -1.52 | -1.04 | -2.53 | |||
| Changes by years, y/y, % | -85% | -87% | -23% | -43% | -31% | -63.9% | |||
Fate Therapeutics. P/FCF
Fate Therapeutics. P/FCF, changes, %
Fate Therapeutics (FATE) P/FCF US GAAP (quarter values) |
||||||||
| 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | LTM ? | |||
| P/FCF | -1.57 | -0.75 | -1.12 | -1.30 | -1.04 | -2.53 | ||
| Changes by years, y/y, % | -41% | -86% | -59% | -58% | -34% | |||
| Changes by quarters, q/q, % | -49% | -52% | +50% | +16% | -20% | |||